ADINA CATALOGUE
Shop the
complete catalogue.
Search by product name or browse by category. Price, availability and the most important distinction stay visible throughout.
Showing all 13 results
-
Experimental

Bronchogen
£46.0020 mgBatch file pendingAirway-tissue focus rather than VIP’s defined VPAC-receptor bronchodilatory biology.
UnavailableAsk about availability -
Experimental

Cartalax
£46.0020 mgBatch file pendingCartilage-cell focus, rather than BPC-157’s broader repair signalling or GHK-Cu’s collagen/copper biology.
UnavailableAsk about availability -
Experimental

Dihexa
£66.0010 mgBatch file pendingHGF/c-Met synaptogenesis hypothesis, unlike Semax’s neurotrophic ACTH-fragment lineage.
UnavailableAsk about availability -
Experimental

Endoluten
£46.0020 mgBatch file pendingPineal/circadian branding with uncertain composition, distinct from sequence-defined Epithalon.
UnavailableAsk about availability -
Experimental

Follistatin 344
£76.001 mgBatch file pendingA ligand-binding inhibitor of the activin/myostatin system, not a GH or IGF secretagogue.
UnavailableAsk about availability -
Experimental

IGF-1 DES
£62.001 mgBatch file pendingA short-acting truncated analogue, contrasted with the extended long-exposure design of IGF-1 LR3.
UnavailableAsk about availability -
Experimental

IGF-1 LR3
£47.991 mgBatch file pendingDesigned for longer, less binding-protein-restricted IGF signalling than native IGF-1 or IGF-1 DES.
Available · 10 in stockAdd to basket -
Experimental

Livagen
£46.0020 mgBatch file pendingA liver-tissue bioregulator concept rather than a systemic metabolic receptor agonist.
UnavailableAsk about availability -
Experimental

P21
£58.0010 mgBatch file pendingA CNTF-lineage neurotrophic research material whose exact sequence must be verified before meaningful comparison.
UnavailableAsk about availability -
Experimental

PEG-MGF
£61.002 mgBatch file pendingA modified splice-variant fragment rather than a direct full IGF-1 receptor analogue.
UnavailableAsk about availability -
Experimental

Pinealon
£46.0020 mgBatch file pendingA tissue-bioregulator concept with uncertain targets, unlike receptor-defined Semax or Selank research.
UnavailableAsk about availability -
Experimental

Vesugen
£46.0020 mgBatch file pendingVascular-tissue focus distinguishes it from mitochondrial or general healthy-ageing peptides.
UnavailableAsk about availability -
Experimental

Vilon
£46.0020 mgBatch file pendingA minimal dipeptide bioregulator, much smaller and less mechanistically defined than thymosin alpha-1.
UnavailableAsk about availability